msd-ertapenem injection
msd (pty) ltd - injection - see ingredients - each vial contains ertapenem sodium ertapenem 1,0 g
msd-caspofungin 50 mg solution
msd (pty) ltd - solution - see ingredients - each vial contains caspofungin acetate equivalent to caspofungin 50,0 mg
msd-caspofungin 70 mg solution
msd (pty) ltd - solution - see ingredients - each vial contains caspofungin acetate equivalent to caspofungin 70,0 mg
msd-sitagliptin 25 mg
msd pty ltd - sitagliptin phosphate - tablet - each film-coated tablet contains sitagliptin phosphate monohydrate equivalent to sitagliptin 25 mg
msd-sitagliptin 50 mg
msd pty ltd - sitagliptin phosphate - tablet - each film-coated tablet contains sitagliptin phosphate monohydrate equivalent to sitagliptin 50 mg
msd-sitagliptin 100 mg
msd pty ltd - sitagliptin phosphate - tablet - each film-coated tablet contains sitagliptin phosphate monohydrate equivalent to sitagliptin 100 mg
msd-sitagliptin/metformin 50/500 mg
msd pty ltd - sitagliptin phosphate; metformin hydrochloride - tablet - each tablet contains sitagliptin phosphate monohydrate equivalent to sitagliptin 50,0 mg and metformin hydrochloride 500,0 mg
msd-sitagliptin/metformin 50/850 mg
msd pty ltd - sitagliptin phosphate; metformin hydrochloride - tablet - each tablet contains sitagliptin phosphate monohydrate equivalent to sitagliptin 50,0 mg and metformin hydrochloride 850,0 mg
msd-sitagliptin/metformin 50/1000 mg
msd pty ltd - sitagliptin phosphate; metformin hydrochloride - tablet - each tablet contains sitagliptin phosphate monohydrate equivalent to sitagliptin 50,0 mg and metformin hydrochloride 1000,0 mg
msd-ertugliflozin-sitagliptin 5/100 ertugliflozin/sitagliptin (as phosphate monohydrate) 5 mg/100 mg film-coated tablet blister
merck sharp & dohme (australia) pty ltd - sitagliptin phosphate monohydrate, quantity: 128.5 mg (equivalent: sitagliptin, qty 100 mg); ertugliflozin pyroglutamic acid, quantity: 6.48 mg (equivalent: ertugliflozin, qty 5 mg) - tablet, film coated - excipient ingredients: magnesium stearate; croscarmellose sodium; sodium stearylfumarate; microcrystalline cellulose; calcium hydrogen phosphate; carnauba wax; titanium dioxide; hypromellose; hyprolose; iron oxide yellow; iron oxide red; iron oxide black - msd-ertugliflozin-sitagliptin (ertugliflozin and sitagliptin phosphate monohydrate) is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus when treatment with both ertugliflozin and sitagliptin is appropriate. [see 5.1 pharmacodynamic properties, clinical trials, and 4.4 special warnings and precautions for use]